XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Total revenue $ 594 $ 1,545 $ 2,610 $ 2,338
Costs and expenses:        
Cost of product revenue 23 148 260 288
Research and development:        
Noncash compensation 2,328 7,016 4,223 14,527
Other research and development 24,546 37,855 70,693 93,438
Total research and development 26,874 44,871 74,916 107,965
Selling, general and administrative:        
Noncash compensation (3,304) 9,288 (3,077) 18,395
Other selling, general and administrative 15,942 24,729 36,324 42,384
Total selling, general and administrative 12,638 34,017 33,247 60,779
Total costs and expenses 39,535 79,036 108,423 169,032
Operating loss (38,941) (77,492) (105,813) (166,694)
Other expense (income):        
Interest expense 3,017 1,623 5,681 3,521
Other income (1,448) (618) (1,971) (1,090)
Total other expense (income), net 1,569 1,005 3,710 2,431
Net loss $ (40,510) $ (78,497) $ (109,523) $ (169,125)
Basic net loss per common share (in dollars per share) $ (0.30) $ (0.59) $ (0.81) $ (1.28)
Diluted net loss per common share (in dollars per share) $ (0.30) $ (0.59) $ (0.81) $ (1.28)
Weighted-average shares used in computing basic net loss per common share (in shares) 134,779,904 132,072,996 134,591,250 131,986,293
Weighted-average shares used in computing diluted net loss per common share (in shares) 134,779,904 132,072,996 134,591,250 131,986,293
Product revenue, net [Member]        
Revenue:        
Total revenue $ 556 $ 1,507 $ 2,534 $ 2,262
License revenue [Member]        
Revenue:        
Total revenue $ 38 $ 38 $ 76 $ 76